The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-15 of 15 articles
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Buccheri S,
Sarno G,
Erlinge D,
Renlund H,
Lagerqvist B,
Grimfjärd P,
Witt N,
Yndigegn T,
Fröbert O,
Persson J,
Böhm F,
James S
April 20, 2021 | 10.4244/EIJ-D-20-00429
Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement
Lansky A,
Cremonesi A,
Scheller B,
James S,
Grubman D,
Fajadet J,
Sauguet A,
Micari A,
Sarno G,
Bosiers M,
Baumbach A,
Wijns W
February 20, 2020 | 10.4244/EIJV15I14A220
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry
Buccheri S,
Sarno G,
Lagerqvist B,
Olivecrona G,
Hambraeus K,
Witt N,
Lindholm D,
Erlinge D,
Angerås O,
James S
August 3, 2018 | 10.4244/EIJ-D-18-00392
A novel dedicated 3-dimensional quantitative coronary analysis methodology for bifurcation lesions
September 30, 2011 | 10.4244/EIJV7I5A100
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G,
Garg S,
Gomez-Lara J,
Garcia-Garcia H,
Ligthart J,
Bruining N,
Onuma Y,
Witberg K,
van Geuns R,
de Boer S,
Wykrzykowska JJ,
Schultz C,
Duckers H,
Regar E,
de Jaegere P,
de Feyter P,
Van Es G-A,
Boersma E,
van der Giessen WJ,
Serruys P
March 21, 2011
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
Garg S,
Sarno G,
Serruys P,
de Vries T,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
June 30, 2010
How should I treat a complex Post-CABG patient?
November 15, 2009 | 10.4244/EIJV5I5A100
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)
Verheye S,
Sarno G,
Muller R,
Birkemeyer R,
Vrints C,
Jung W,
Agostoni P,
van Langenhove G,
Haine S,
Willems T,
Haude M,
Grube E,
Wijns W
June 30, 2009 | 10.4244/EIJV5I2A36
Latest news
AHEAD OF PRINT
Design of the TARGET-FIRST randomised study
FREE ARTICLE - Giuseppe Tarantini et al
March 31, 2023
AHEAD OF PRINT
Oesophageal and gastric injuries in tricuspid TEER
FREE ARTICLE - Tanja Kuecken et al
March 29, 2023
AHEAD OF PRINT
Heavily calcified CTOs: an expert review from the European CTO Club
FREE ARTICLE - Kambis Mashayekhi et al
March 27, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023